Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ismigen

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Broncho-Vaxom

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Bacterial lysates in the prevention of respiratory tract infections.
Bacterial lysates stimulate the general immunity of the body in a non-specific way. They act on non-specific defense mechanisms… Expand
Is this relevant?
2017
2017
ISMIGEN IN COMPLEX TREATMENT OF CHILDREN WITH BRONCHIAL ASTHMA
 
Is this relevant?
2016
2016
Новые возможности терапии и профилактики осложнений инфекционно-воспалительных заболеваний верхних дыхательных путей
Abstract. SARS in the overwhelming majority of cases are the initial link in the chain of pathological changes developing in… Expand
Is this relevant?
2015
2015
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD…
Polyvalent mechanical bacterial lysates (PMBLs) have been shown to reduce the number of infectious episodes in patients with… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2014
2014
Clinical evaluation of a sub-lingual vaccine for prevention of exacerbations in COPD
Background: Lower airway bacterial infection is one of the major cause for exacerbation inCOPD. Multicomponent vaccines derived… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone
Background: This study investigated the value of adding Ismigen®, a polyvalent mechanical bacterial lysate, to therapy of COPD… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2005
2005
Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
One hundred and fourteen patients with a medical history of recurrent upper respiratory tract infections (at least four episodes… Expand
Is this relevant?
2004
2004
Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
UNLABELLED The aim of the present study was to evaluate the efficacy of the immunostimulating therapy with a new vaccine Ismigen… Expand
Is this relevant?
2004
2004
Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
The aim of the present trial was the assessment of the efficacy and safety of a treatment with Ismigen®, a new immuno-stimulating… Expand
Is this relevant?
2003
2003
Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels.
Lyophilized bacterial lysates, which actively stimulate the immune response, are widely used as vaccines or 'biological response… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE